Title of article
Propranolol in Infantile Hemangioma: A Review Article
Author/Authors
Mansouri ، Parvin نويسنده Dermatologist, Imam Khomeini Hospital, Tehran University of Medical Sciences , , Hejazi، Somayeh نويسنده Department of Dermatology, Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. , , Ranjbar، Maryam نويسنده Iran Language Institute , , Shakoei، Safoura نويسنده Skin and Stem cell Research Center, Tehran University of Medical Sciences, Tehran, Iran ,
Issue Information
فصلنامه با شماره پیاپی 0 سال 2014
Pages
1
From page
0
To page
0
Abstract
Hemangioma is the most common benign cutaneous vascular tumor in infants and children. The Hemangioma incidence in the neonates is 2% to 3% that increases to 10% in those younger than one year of age. Before introduction of propranolol in 2008, different medications such as systemic corticosteroids and vincristine, with different side effects, were used for years. Since then, over 200 studies concerning propranolol administration have been published. This study reviews propranolol use in infantile hemangioma.
Journal title
Journal of Skin and Stem Cell
Serial Year
2014
Journal title
Journal of Skin and Stem Cell
Record number
2233209
Link To Document